Regulation of the Pharmaceutical Industry

Inbunden, Engelska, 2003

Av J. Abraham, H. Lawton Smith, John Abraham, Helen Lawton Smith, H Lawton Smith

1 459 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

How are pharmaceutical technologies developed and controlled in our societies? To what extent should the availability of these technologies be determined by scientific experts, a democratic state, the interests of final users, or ethical principles? This unique collection brings together the work of social scientists, ethicists, lawyers and policy analysts on regulation, ethics and innovation in the pharmaceutical industry. Regulatory systems and their implications for public health in North America, Europe and developing countries are discussed, including case studies of norplant, interferon and anti-fertility vaccines.

Produktinformation

Utgivningsdatum2003-06-10
Mått140 x 216 x 20 mm
Vikt477 g
FormatInbunden
SpråkEngelska
SerieStudies in Regulation
Antal sidor278
Upplaga2003
FörlagPalgrave Macmillan
ISBN9780333790441

Tillhör följande kategorier

OONAGH CORRIGAN Post-Doctoral Research Fellow, Department of Sociology, Goldsmiths College, University of London, UKARTHUR DAEMMRICH Policy Analyst and Post-Doctoral Research Fellow, Chemical Heritage FoundationCLAIRE FOSTER Secretary for Science, Medicine, Technology and Environmental Issues, Church of England's Board for Social ResponsibilityMORVEN HADDEN Senior Assistant in the EC and Competition Law Group of Simmons and Simmon Law Firm, London, UKELINA HEMMINKI Research Professor, National Research and Development Centre for Welfare and Health (STAKES), Helsinki, FinlandHELEN KELLY Senior Assistant, Matheson, Ormsby and Prentice Law FirmGRAHAM LEWIS Research Fellow, University of York, UKNORMA MORRIS Research Fellow, University College London, UKEEVA OLLILA Senior Research Fellow, National Research and Development Centre for Welfare and Health, Helsinki, FinlandTOINE PETERS Professor in the History of Pharmacy, Groningen University, The NetherlandsTIM REED Research Fellow, University of Sussex, UKJESSIKA VAN KAMMEN Project Leader, STT Netherlands Study Centre on Technology Trends

List of Tables and Figures Notes on the Contributors Acknowledgements Introduction; J.Abraham Regulatory Laws and Political Culture in the United States and Germany; A.Daemmrich Europeanization of Medicines Regulation; J.Abraham & G.Lewis Globalization of Medicines Control; J.Abraham & T.Reed Sales Licensing Documentation and Trade Secrecy: The Case of Norplant Contraceptives; E.Ollila & E.Hemminki Biological Medicines in the Age of Biotech: Public Policy Issues; N.Morris New Molecules, Markets and Changing Drug Regulatory Practices; T.Peters Users' Involvement in Regulating Contraceptive Innovation: The Design of Anti-Fertility Vaccines; J.van Kammen Regulations for Ethical Purposes: Medical Research on Humans; C.Foster The Limitations of Current Ethical Regulations; O.Corrigan Mergers and Joint Ventures in the Pharmaceutical Industry; H.Kelly & M.Hadden